Detalhe da pesquisa
1.
Phase 3 Trial of Crinecerfont in Adult Congenital Adrenal Hyperplasia.
N Engl J Med
; 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38828955
2.
A phase 1 study of nevanimibe HCl, a novel adrenal-specific sterol O-acyltransferase 1 (SOAT1) inhibitor, in adrenocortical carcinoma.
Invest New Drugs
; 38(5): 1421-1429, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31984451
3.
Ferric pyrophosphate citrate (Triferic™) administration via the dialysate maintains hemoglobin and iron balance in chronic hemodialysis patients.
Nephrol Dial Transplant
; 30(12): 2019-26, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26175145
4.
Investigating the relative merits of using a mixed reality context for measuring affective response and predicting tea break snack choice.
Food Res Int
; 150(Pt A): 110718, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34865749
5.
A Phase 2, Multicenter Study of Nevanimibe for the Treatment of Congenital Adrenal Hyperplasia.
J Clin Endocrinol Metab
; 105(8)2020 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32589738
6.
Neurokinin 3 receptor antagonism rapidly improves vasomotor symptoms with sustained duration of action.
Menopause
; 25(8): 862-869, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29533369
7.
One-year long-term safety extension study of ospemifene for the treatment of vulvar and vaginal atrophy in postmenopausal women with a uterus.
Menopause
; 20(4): 418-27, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23096251